Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Oncology Reports
|
November 18, 2015
Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells
Xinhua Xu, Yang Liu, Jin Su, et al.
The Plant Journal : for Cell and Molecular Biology
|
January 27, 2023
Arabidopsis SMO2 modulates ribosome biogenesis by maintaining the RID2 abundance during organ growth
Zhengfei Guo, Xiaoyu Wang, Yan Li, et al.
Plant, Cell & Environment
|
June 25, 2025
Maize ZmDLR2/BRU1 Is Required for Lateral Root Primordium Emergence by Participating in DNA Repair
Daojun Li, Yudong Wang, Yan Li, et al.
Frontiers in Immunology
|
September 12, 2022
Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study
Dailong Li, Lu Xu, Jinxing Ji, et al.
Cancer Cell
|
March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Zi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Oncology Reports
|
November 18, 2015
Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells
Xinhua Xu, Yang Liu, Jin Su, et al.
The Plant Journal : for Cell and Molecular Biology
|
January 27, 2023
Arabidopsis SMO2 modulates ribosome biogenesis by maintaining the RID2 abundance during organ growth
Zhengfei Guo, Xiaoyu Wang, Yan Li, et al.
Plant, Cell & Environment
|
June 25, 2025
Maize ZmDLR2/BRU1 Is Required for Lateral Root Primordium Emergence by Participating in DNA Repair
Daojun Li, Yudong Wang, Yan Li, et al.
Frontiers in Immunology
|
September 12, 2022
Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study
Dailong Li, Lu Xu, Jinxing Ji, et al.
Cancer Cell
|
March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Zi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Page
of 2